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Mechanism of actin N-terminal acetylation
Grzegorz Rebowski1*, Malgorzata Boczkowska1*, Adrian Drazic2, Rasmus Ree2, Marianne Goris3, 
Thomas Arnesen2,3,4, Roberto Dominguez1†
About 80% of human proteins are amino-terminally acetylated (Nt-acetylated) by one of seven Nt-acetyltransferases 
(NATs). Actin, the most abundant protein in the cytoplasm, has its own dedicated NAT, NAA80, which acts post-
translationally and affects cytoskeleton assembly and cell motility. Here, we show that NAA80 does not associate 
with filamentous actin in cells, and its natural substrate is the monomeric actin-profilin complex, consistent with 
Nt-acetylation preceding polymerization. NAA80 Nt-acetylates actin-profilin much more efficiently than actin alone, 
suggesting that profilin acts as a chaperone for actin Nt-acetylation. We determined crystal structures of the 
NAA80-actin-profilin ternary complex, representing different actin isoforms and different states of the catalytic 
reaction and revealing the first structure of NAT-substrate complex at atomic resolution. The structural, biochemical, 
and cellular analysis of mutants shows how NAA80 has evolved to specifically recognize actin among all cellular 
proteins while targeting all six actin isoforms, which differ the most at the amino terminus.
INTRODUCTION
N-terminal acetylation (Nt-acetylation) is a prevalent modification 
that affects ~80% of human proteins and can have a major impact 
on human health and disease (1–4). The reaction is catalyzed by one 
of seven Nt-acetyltransferases (NATs) (NatA to NatF and NatH), 
whose catalytic subunits (NAA10 to NAA60 and NAA80) display a 
common fold but low sequence identity. The NATs transfer the ace-
tyl group (COCH3) from acetyl coenzyme A (AcCoA) onto the free 
N-terminal -amino group of their protein substrates. Five of 
the NATs (NatA to NatE) associate with the ribosome and act 
cotranslationally, whereas NatF binds to the Golgi membrane and 
Nt-acetylates transmembrane proteins (5). Most NATs are rather 
promiscuous, acting on large subsets of proteins. One exception is 
NatD, which Nt-acetylates only two substrates, histones H2A and 
H4 (6). In addition, we recently found that actin, the most abundant 
protein in the cytoplasm of eukaryotic cells, has its own dedicated 
NAT, NAA80 (7). Actin Nt-acetylation is also unique in that it pro-
ceeds through a multistep mechanism that involves both co- and 
posttranslational modification (8, 9). During translation, the ini-
tiator methionine (iMet) of the two cytoplasmic actin isoforms is 
Nt-acetylated, whereas the iMet of the four-muscle actin isoforms 
is removed and the exposed cysteine is Nt-acetylated by one of the 
ribosome-associated NATs. This is followed by the removal of the 
N-terminal Ac-Met (or Ac-Cys) by a still unidentified acetylamino-
peptidase. Then, all six actin isoforms, which at this point carry either 
three (cytoplasmic /-actin and smooth muscle -actin) or four 
(muscle -actin isoforms) negatively charged amino acids at the N 
terminus, are posttranslationally Nt-acetylated by NAA80 (7, 10). 
NAA80 is highly specific, targeting only actin among all the pro-
teins in the cell, whereas its knockout (KO) completely abolishes 
actin Nt-acetylation, showing that no other NAT can substitute for 
NAA80. Actin’s acetylated N terminus is prominently exposed in the 
actin filament where it can interact with many filamentous actin- 
binding proteins (ABPs) (9), and consistently, actin Nt-acetylation 
critically affects filament assembly in vitro and in cells. In vitro, the 
absence of Nt-acetylation leads to a decrease in the rates of filament 
depolymerization and elongation, including formin-induced elon-
gation, whereas NAA80 KO cells display increased filopodia and 
lamellipodia formation and accelerated cell motility (7, 9). Here, we 
describe the mechanism of actin Nt-acetylation by NAA80. Bio-
chemical, structural, and cellular data show how NAA80 has evolved 
to specifically recognize the complex of actin-profilin while being 
able to Nt-acetylate all six actin isoforms, which diverge the most at 
the N terminus.
RESULTS
NAA80 targets monomeric actin in vitro and in cells
The seven human NATs have a common catalytic core, but they 
share low sequence conservation, with NAA80 being the most di-
vergent of them all (fig. S1). NAA80 shares only 16.9% sequence 
identity with its closest relative, NAA20, and contains a divergent 
77–amino acid N-terminal extension and a unique 70–amino acid 
Pro-rich loop inserted before the last -strand of the catalytic do-
main (Fig. 1A). N- and C-terminal extensions are common among 
the NATs and are typically implicated in the recruitment of auxil-
iary subunits that regulate the catalytic activity and subcellular local-
ization (2). We asked whether NAA80’s N-terminal extension plays 
a role in its activity and/or localization and whether NAA80 targets 
monomeric (G-actin) or filamentous (F-actin) actin in cells.
In vitro, we found that full-length NAA80 (NAA80FL) and a con-
struct lacking the N-terminal extension, residues 78 to 308 (NAA80N), 
can both Nt-acetylate /-actin purified from NAA80 KO HAP1 
cells, as confirmed by Western blot analysis with isoform- and 
Nt-acetylation–specific anti–Ac--actin antibodies (Fig. 1B). In 
cells, the expression of green fluorescent protein (GFP)–NAA80N, 
but not GFP alone, rescued /-actin acetylation in NAA80 KO cells 
(Fig. 1C). Thus, while the N-terminal extension may play a role 
in localization and/or modulation of the catalytic activity, it appears 
to be dispensable for Nt-acetylation in vitro and in cells.
We then performed cell fractionation assays to assess whether 
NAA80 associates with the soluble, G-actin–containing, or the pel-
let, F-actin–containing, fraction in cells. Endogenous NAA80 was 
found predominantly in the soluble fraction, analogous to profilin, 
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Fig. 1. NAA80 preferentially binds monomeric actin in vitro and in cells. (A) Domain diagram of NAA80, showing the two major constructs used in this study. (B) In 
vitro acetylation by NAA80N (lacking the 77–amino acid N-terminal extension, or N) of nonacetylated /-actin analyzed by Western blotting, using acetylation- and 
isoform-specific anti–Ac--actin antibody. Ac-/-actin purified from WT cells and actin acetylated by full-length NAA80 (NAA80FL or FL) were used as controls. Loading 
was controlled by anti–pan-actin staining. (C) Rescue of acetylation in NAA80 KO cells by NAA80N analyzed as in (B). Lysate from WT cells was used as a control. Anti–green 
fluorescent protein (GFP) staining confirmed NAA80N expression in cells. (D) Western blot analysis of the presence of endogenous NAA80 in the soluble (G-actin) and pellet 
(F-actin) fractions of HAP1 WT cells using custom anti-NAA80 antibody (1:200). Controls are profilin, which binds only G-actin, and Dia1, which binds both G- and F-actin. 
NAA80 KO cells are shown as a control for custom antibody specificity. Left: Representative Western blots (fig. S8). Right: Quantifications, showing data points (red circles) 
and means ± SD (n = 5). The statistical significance of the data was determined using an unpaired two-sided Student’s t test (***P < 0.001). (E) Representative HeLa cells ex-
pressing GFP-NAA80FL (GFP-FL) or GFP-NAA80N (GFP-N) and stained with Alexa Fluor 546 phalloidin to visualize F-actin. Scale bar, 10 m. Line scans illustrate the lack of 
NAA80 colocalization with F-actin, as also confirmed by whole-cell correlation coefficient analysis on n = 15 cells (fig. S2, D and E). (F) Cosedimentation of NAA80FL with F-actin 
(Ac--actin) ± tropomyosin (Tpm). Data points correspond to the mean from three independent experiments ± SEM (fig. S7A). The maximum molar binding ratio (Bmax) and 
observed dissociation constant (Kobs) were calculated using a nonlinear least square fit (see Materials and Methods). (G and H) Isothermal titration calorimetry (ITC) titrations 
of NAA80FL and NAA80N (CoA) into Ac--actin (latrunculin B, or LatB), using the indicated experimental conditions. The dissociation constant (KD) and binding stoichiometry 
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a prototypical G-actin–binding protein (Fig. 1D). In contrast, the 
formin Dia1, which can bind both G- and F-actin, appeared in the 
soluble and pellet fractions. We also analyzed three V5-tagged con-
structs (NAA80FL, NAA80N, and the catalytically inactive mutant 
NAA80CM) expressed in wild-type (WT) and NAA80 KO cells. 
Analogous to endogenous NAA80, all three constructs were pre-
dominantly associated with the soluble fraction (fig. S2A). We note, 
however, that NAA80N was slightly more likely to be found in the 
pellet fraction, suggesting that the N-terminal tail of NAA80 inter-
feres somewhat with binding to F-actin in cells. The relative amount 
of endogenous and exogenously expressed NAA80FL in the pellet 
fraction was always less than 10%, even when their relative abun-
dance was approximately 1:1200 (fig. S2B). It thus appears that NAA80 
does not associate with the F-actin–containing fraction even when 
present at high levels.
Consistent with these results, constructs GFP-NAA80FL and 
GFP-NAA80N expressed in HeLa cells did not colocalize with Alexa 
Fluor 546 phalloidin–stained F-actin fibers and displayed a cyto-
solic localization similar to that of the mCherry control (Fig. 1E and 
fig. S2D). This result was corroborated through whole-cell quantifi-
cation of the amount of overlap between the fluorescent intensities 
of GFP and Alexa Fluor 546 (or mCherry) (fig. S2E). GFP-NAA80FL 
also did not colocalize with mitochondria (DsRed-Mito) and endo-
plasmic reticulum (mCherry-Sec61B and mCherry-calnexin) markers 
and appeared to be excluded from these organelles (fig. S2F).
Combined, these observations suggest that NAA80 associates 
with the G-actin and not the F-actin pool in cells. Moreover, this 
localization is mostly independent of the presence/absence of the 
N-terminal extension of NAA80 or whether actin is Nt-acetylated. 
Construct NAA80CM that fails to rescue actin Nt-acetylation in 
NAA80 KO cells (7) was also found in the G-actin fraction (fig. S2A).
Next, we tested binding of NAA80 to G- and F-actin in vitro. In 
these experiments, we first used -skeletal actin, which is N-terminally 
acetylated (Ac--actin), and NAA80 with CoA bound. In cosedi-
mentation assays, NAA80 bound F-actin with an observed dissoci-
ation constant (Kobs) of 0.73 M (Fig. 1F), which contrasted with 
the apparent lack of binding in cells. A recent study, however, sug-
gests that most actin filaments in cells are associated with tropo-
myosin (Tpm) (11), which acts as the gatekeeper of the actin filament 
(12). To test whether Tpm competes with NAA80 for binding to F-actin, 
we performed cosedimentation assays with Tpm-decorated filaments. 
Tpm reduced the affinity of NAA80 for F-actin approximately ninefold 
(Kobs of 6.4 M), suggesting at least partial competition (Fig. 1F and 
see Discussion).
Binding to G-actin was quantitatively assessed using isothermal 
titration calorimetry (ITC). In these experiments (Fig. 1, G and H), 
latrunculin B (LatB) was used to prevent actin polymerization. Both, 
NAA80FL and NAA80N bound Ac--actin with similarly high af-
finities (dissociation constant, KD of 0.26 and 0.19 M, respectively) 
and ~1:1 stoichiometry, suggesting that the N-terminal extension does 
not participate in actin binding. Therefore, NAA80 has substantially 
higher affinity for G- than F-actin, particularly considering that in 
cells, competition with Tpm is likely, which might explain the lack 
of colocalization with F-actin.
Profilin acts as a chaperone for actin  
Nt-acetylation by NAA80
In cells, the G-actin pool exists mostly in the form of complexes 
with ABPs (13, 14). Therefore, we tested the ability of NAA80 to 
bind to some of the most common actin-ABP complexes. By ITC, 
NAA80N (CoA) failed to bind the complexes of Ac--actin with 
gelsolin segment 1 (GS1) and thymosin 4, suggesting direct com-
petition with these two proteins (fig. S3, A, B, and D). In contrast, 
NAA80N (CoA) bound with high-affinity the complex of Ac--actin 
with deoxyribonuclease I (DNase I) (fig. S3C).
Profilin is the most abundant ABP in cells (13). With a cellular 
concentration of 50 to 100 M, a high affinity for adenosine tri-
phosphate (ATP)–G-actin (KD of 0.1 M) (15), as well as the ability 
to compete with T4 for binding to actin monomers (16), profilin- 
actin accounts for the largest fraction of monomeric actin in cells 
(13). Both NAA80FL and NAA80N bound the complex of Ac--
actin–profilin with similarly high affinities (KD of 0.23 and 0.15 M, 
respectively) (Fig. 2, A and B). This result also suggests that the 
N-terminal extension of NAA80 is not necessary for binding to actin- 
profilin.
Since NAA80 targets the N terminus of actin, which varies 
among isoforms, we asked whether its preference for the monomer 
was also observed with /-actin. In cosedimentation assays, NAA80FL 
bound the Ac-/-actin filament with a Kobs of 5.2 M (Fig. 2C), 
whereas by ITC, NAA80N bound both Ac-/-actin–profilin and 
nonacetylated /-actin–profilin with ~2.5-fold higher affinity (KD 
of 2.4 and 1.8 M, respectively) (Fig. 2, D and E). While these mea-
surements confirm NAA80’s preference for the monomer, inde-
pendent of actin isoform, it is interesting that NAA80 binds -actin 
(both monomer and filament) with ~16-fold higher affinity than 
/-actin (Fig. 2, B and D), showing the importance of actin’s vari-
able N terminus for recognition by NAA80.
Pro-rich sequences are abundant among cytoskeletal proteins 
and are typically implicated in the binding of profilin or SH3- 
containing proteins (17). The Pro-rich loop of NAA80 contains a 
canonical profilin-binding site (261PPLPPPPPLP270) (18, 19), sug-
gesting that NAA80 may interact directly with profilin. Consistent 
with this idea, NAA80N bound profilin with ~1:1 stoichiometry 
(Fig. 2F), albeit with relatively low affinity (KD of 30 M), which 
is similar to other profilin interactions with Pro-rich sequences 
(18, 19).
Together, these results suggest that actin-profilin, not just actin, 
is the preferred NAA80 substrate. To further test this idea, we asked 
whether profilin modulates the catalytic activity of NAA80 toward 
actin. We compared the extent of Nt-acetylation of /-actin puri-
fied from NAA80 KO cells alone and in complex with profilin using 
isoform- and acetylation-specific anti–-actin antibodies. The pres-
ence of profilin significantly enhanced the Nt-acetylation efficiency 
of NAA80 as a function of reaction time and enzyme:substrate ratio 
(Fig. 2G). Together, the results presented here suggest that profilin acts 
as a chaperone for actin Nt-acetylation. Moreover, Nt-acetylation 
is likely to occur before polymerization since profilin acts as the 
main carrier of actin monomers into filaments due to its ability to 
bind Pro-rich sequences in actin assembly factors such as formins 
and vasodilator-stimulated phosphoprotein (VASP) (13, 14).
The NAA80 structure is specifically adapted to recognize 
the actin-profilin complex
So far, a structure of a NAT bound to its entire substrate had not 
been determined, possibly because the NATs are rather promis-
cuous and bind their substrates transiently during translation (2). 
The specificity and relatively high affinity of NAA80 for its substrate 










Rebowski et al., Sci. Adv. 2020; 6 : eaay8793     8 April 2020
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
4 of 13
350 M N (CoA)
24 M Ac- / -actin–profilin
Time (min)

























0 0.5 1.51.0 2.0 2.5
Molar ratio
KD = 2.4 ± 0.1 µM






























E 350 M N (CoA)
22 M / -actin–profilin
Time (min)











KD = 1.8 ± 0.1 µM
N = 1.04 ± 0 .01  
3.0 3.5
T = 20°C
FL (CoA) + F-actin (Ac- / -actin)
Bmax = 1.33 ± 0.14
Kobs = 5.21 ± 1.44 M
F
70 M FL (CoA)






























0 40 80 120
A 90 M N (CoA)















0 0.5 1.51.0 2.0
T = 20°C
Molar ratio
0 40 80 120
B
425 M profilin
27.5 M N (CoA)
KD = 30 ± 2 µM












0 40 80 120
C
KD = 0.23 ± 0.01 µM
N = 0.91 ± 0.03
KD = 0.15 ± 0.01 µM
N = 1.08 ± 0.01 
FL : / -actin
1:50 1:100 1:200 1:400 1:50 1:100 1:200 1:400










































































































Fig. 2. Complex of actin-profilin is a preferred substrate of NAA80. (A and B) ITC titrations of NAA80FL (FL) and NAA80N (N) with bound CoA into Ac--actin–profilin 
(LatB) using the indicated experimental conditions. The KD and binding stoichiometry (N) were derived from fitting to a one-site binding isotherm (red line). Errors corre-
spond to the SD of the fits. Open symbols correspond to control titrations into buffer. (C) Cosedimentation of NAA80FL with F-actin (Ac-/-actin). Data points correspond 
to the mean from three independent experiments ± SEM (fig. S7B). The maximum molar binding ratio (Bmax) and Kobs were calculated using a nonlinear least square fit. 
(D and E) ITC titrations of NAA80N (CoA) into acetylated and nonacetylated /-actin-profilin (LatB), using the indicated experimental conditions. The KD and binding 
stoichiometry (N) were derived from fitting to a one-site binding isotherm (red line). Errors correspond to the SD of the fits. Open symbols correspond to control titrations into 
buffer. (F) ITC titrations of profilin into NAA80N (CoA), using the indicated experimental conditions and analyzed as above. (G) In vitro acetylation of 10 M nonacetylated 
/-actin alone or in complex with profilin by NAA80FL, analyzed by Western blotting using acetylation- and isoform-specific anti–Ac--actin antibody. The conditions of the 
acetylation reaction (NAA80FL:actin or NAA80FL:actin-profilin ratio and time) are indicated in the figure. Loading was controlled by anti–pan-actin staining. Left: Representative 
Western blot. Right: Quantification from three independent experiments. For each blot, the band intensities were normalized to the 1:50 NAA80FL:actin- profilin band. 
Shown are mean relative intensities ± SD (n = 3) and individual data points (red open circles). The statistical significance was determined using an unpaired two- 
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NAA80N with actin-profilin, corresponding to different steps along 
the catalytic pathway and different actin isoforms (Fig. 3, Table 1, 
fig. S4, and movie S1). One structure represents the first step in the 
catalytic reaction, i.e., before the acetyl group is transferred onto the 
protein substrate. This structure contains nonacetylated /-actin 
(i.e., a mixture of the two cytoplasmic isoforms purified from 
NAA80 KO cells) in complex with profilin and NAA80N with 
bound acetonyl-CoA (AnCoA), a nonhydrolyzable AcCoA analog. 
The second structure is that of Ac--actin–profilin in complex with 
NAA80N (CoA), corresponding to a state in which the acetyl group 
has already been transferred onto the actin substrate. This structure 
has the highest resolution (2.0 Å) among the three described here 
(Table 1) and is thus used in most illustrations. The third structure 
is that of Ac--actin–profilin in complex with NAA80N (AcCoA), 
representing the last step in the catalytic reaction, i.e., the release of 
the protein substrate prompted by NAA80 reloading with AcCoA. 
In this structure, the acetyl groups on AcCoA and actin sterically 
hinder one another, and, consequently, the affinity of NAA80 for 
Ac--actin–profilin is ~8.5-fold lower (KD of 1.7 M) with AcCoA 
than with CoA (compare Fig. 2A and fig. S4D).
 The three structures are very similar, with the most important 
differences centered around the variable N termini of actin (fig. S4, 
A to C). NAA80 buries a large surface of 4160 Å2 on actin-profilin 
(3199 Å2 on actin and 961 Å2 on profilin). For comparison, profilin 
buries a surface of 2630 Å2 on actin. The NAA80-binding surface 
can be conceptually divided into three areas: the profilin-binding 
site, the actin-binding surface, and the actin N-terminus–binding 
site (Fig. 3 and movie S1). The profilin-binding site appears to be 
mostly conserved between the two major profilin isoforms (1 and 2), 
although it contributes modestly to the overall binding affinity of 
NAA80 to actin-profilin (Fig. 2F).
NAA80 interacts almost exclusively with actin subdomain 1, 
contacting a surface that is both conserved among actin isoforms 
and highly specific for NAA80. Actin is highly conserved from yeast 
to humans, and sequence identity among the six human isoforms 
ranges from 93.3 to 98.9% (9). In contrast, sequence identity among 
the seven human NATs is low, ranging from 7.9 to 29.9% (fig. S1). 
As a result, the surface that actin presents to NAA80 is strictly con-
served (Fig. 3B), whereas the counterpart surface on NAA80 is 
highly variable among the NATs (Fig. 3C) but tailored specifically 
for actin binding through adaptations of the sequence and structure, 
including repositioning of the loop-helix T105-Q118, the absence 
of -strand 6, a unique loop Q294-P300, and charge complementarity 
with actin (fig. S5, A and B).
The N terminus is the most variable region among actin iso-
forms, and it is one amino acid shorter in cytoplasmic /-actin than 
in skeletal -actin (Figs. 3B and 4A). In most actin structures, the N 
terminus is disordered, whereas in the structures described here, it 
adopts an extended conformation along one-half of the catalytic 
cleft of NAA80, with the other half being occupied by the AcCoA 
derivative (Fig. 3A and fig. S4, A to C). Among the NATs, the region 
of the cleft that binds the substrate N terminus is variable, whereas 
the AcCoA-binding site is conserved (Fig. 3C). The actin N terminus 
is well defined in the electron density maps of the two structures 
containing Ac--actin, whereas the nonacetylated N terminus of 
/-actin is less well resolved, which is probably due to the presence of 
a mixture of isoforms in this structure (fig. S4A). In nonmuscle cells, 
cytoplasmic - and -actin are typically found at a ratio of 2:1 (20), 
and thus, we modeled the N terminus of the nonacetylated struc-
ture using the more abundant -actin sequence. Despite these ambi-
guities, the N termini of /-actin seem to bind NAA80 in a similar 
manner to that of Ac--actin (fig. S4). In support of this conclusion, 
CoA and the first three amino acids of Ac--actin superimpose well 
with a bisubstrate analog consisting of AcCoA covalently attached 
to the first four amino acids of -actin, as observed in a recent struc-
ture of Drosophila NAA80 (fig. S5, C and D) (21). Only the fourth 
amino acid of the bisubstrate analog displays a different orientation 
than that of the natural actin substrate. More generally, the catalytic 
core of Drosophila NAA80 superimposes well with that of human 
NAA80 (a root mean square deviation of 0.82 Å for 119 equivalent 
C atoms) despite the absence of a bound substrate in the Drosophila 
structure and considering that the two proteins share only 30% se-
quence identity. Drosophila NAA80 also lacks the N-terminal exten-
sion and the Pro-rich loop (fig. S5C), suggesting that in Drosophila, 
profilin is unlikely to play a role in actin Nt-acetylation.
NAA80 is specifically adapted to recognize  
all six actin isoforms
In NAA80, the region of the catalytic site that binds the actin N 
terminus is shaped in the form of an open cleft, as opposed to a 
narrow tunnel in other NATs (21), and it is also positively charged, 
which counters actin’s negatively charged N terminus (Fig. 3, B and 
C, and fig. S5B). The charge complementarity between actin and 
NAA80 extends beyond the N terminus–binding site, with the entire 
contact surface being predominantly negatively charged in actin 
and positively charged in NAA80 (Fig. 3, B and C). In this way, 
NAA80 appears to have evolved a catalytic cleft adapted to recognize 
the variable but negatively charged N termini of the actin isoforms, 
whereas other contacts appear to specifically adapt this enzyme for 
recognition of a single substrate in the cell, actin-profilin.
To further test this idea, we asked whether NAA80 could acety-
late N-terminal peptides from other actin isoforms. We found that 
NAA80 expressed in either mammalian cells or Escherichia coli was 
able to effectively acetylate N-terminal peptides from the six actin 
isoforms expressed in humans but not a prototypical NatA/NAA10- 
substrate peptide (Fig. 4B). This result confirms the specificity of 
NAA80 for actin N-terminal peptides independent of isoform and 
expands upon previous studies that showed NAA80’s ability to 
Nt-acetylate cytoplasmic - and -actin and skeletal -actin (7, 22). 
These data also suggest that NAA80 has lower catalytic efficiency 
toward the skeletal -actin peptide. We cannot be sure that the dif-
ferences in NAA80’s catalytic efficiency toward N-terminal peptides 
hold true for the full-length substrates. Yet, we have shown here that 
NAA80N (CoA) interacts ~16-fold more tightly with skeletal Ac--
actin–profilin than cytoplasmic Ac-/-actin–profilin (Fig. 2, B and D), 
suggesting that substrate release after Nt-acetylation may be slower 
for Ac--actin–profilin, thus resulting in reduced Nt-acetylation 
efficiency toward this isoform. In muscle sarcomeres, -actin has a 
particularly long half-life of ~20 days (23), such that a somewhat 
reduced efficiency of NAA80 toward this isoform is unlikely to be-
come a limiting factor in vivo.
Next, we tested the in vitro and cellular activity of four NAA80 
mutants (M1 to M4) targeting groups of amino acids on the actin- 
profilin–binding surface (Fig. 4C). As expected, these mutants, 
which leave the catalytic cleft intact, had approximately the same 
in vitro activity as WT NAA80 toward N-terminal peptides cor-
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Fig. 3. Structural basis of NAA80 binding to actin-profilin. (A) Structure of the ternary complex of NAA80N (N) with CoA bound (magenta), Ac--actin (LatB; blue), 
and profilin (green). Gray broken lines illustrate two flexible regions of NAA80 that were not visualized in the electron density map. A zoom in the middle highlights the 
catalytic cleft of NAA80 (indicated by a rectangle), showing CoA and the acetylated N terminus of -actin. Key amino acids are numbered. (B and C) Analysis of actin- 
NAA80 contact interface according to sequence conservation and charge complementarity. Conservation scores (fig. S1) were plotted onto the surfaces of Ac--actin and 
NAA80 derived from the structure of their complex. Amino acid conservation decreases from green to magenta (as indicated), using a conservation range of 100 to 50% 
for actins (which are highly conserved) and 100 to 0% for the NATs (which are poorly conserved). The contact surfaces on actin (blue) and NAA80 (magenta) are highlighted 
yellow, and the profilin contact surface is highlighted green. Actin subdomains are numbered 1 to 4 (bold, italic characters). NAA80 interacts almost exclusively with actin 
subdomain 1, whose surface is predominantly negatively charged, whereas the counterpart contact surface on NAA80 is mostly positively charged, as revealed by their 
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We then tested the effect of the mutations on the activity and 
interaction of NAA80 with full-length actin. By ITC, mutant M4, 
combining two groups of mutations (M1 and M2), did not bind Ac-
-actin (Fig. 4E). Consistently, mutant M4 was also unable to 
Nt-acetylate /-actin purified from NAA80 KO cells (Fig. 4F). The 
four mutants were then expressed in NAA80 KO cells and their ac-
tivities compared to that of WT NAA80 (Fig. 4G). Alone, mutants 
M1 and M2, but not M3, significantly reduced the ability of NAA80 
to acetylate - and -actin in cells. Mutant M4, targeting the actin- 
binding (M1) and profilin-binding (M3) surfaces, completely elim-
inated NAA80’s ability to Nt-acetylate - and -actin. These results 
show that NAA80 specifically recognizes its actin-profilin substrate 
through extensive surface contacts and not only the N terminus, 
as do other NATs. Moreover, while on its own, the profilin-binding 
site has weak affinity (Fig. 2F) and contributes little toward the cat-
alytic activity (Fig. 4G), but together with other contacts on the actin 
surface, it adds to the exquisite specificity and enhanced activity of 
NAA80 for actin-profilin (Fig. 2G).
There is approximately one NAA80 molecule for every 
 3000 actin molecules in cells
Given the NAA80’s exclusive specificity for actin, we asked what 
was the cellular ratio of enzyme to substrate. By calibrating the rel-
ative concentration of NAA80 and actin in protein lysates against 
purified proteins, we estimated that there is approximately one 
NAA80 enzyme per ~3000 actin molecules (Fig. 5). This relatively 
small amount of NAA80 appears nonetheless sufficient to Nt-acetylate 
the small population of newly translated actin, considering that actin 
has a long half-life in muscle sarcomeres (23) and nonmuscle cells 
(24) and ~100% of it is Nt-acetylated (7).
DISCUSSION
Actin occupies a special place in the cell; it is the most abundant 
protein in the cytoplasm, participates in more protein-protein inter-
actions than any other protein, and is highly conserved (13, 14). 
While the six actin isoforms diverge the most at the N terminus 
(Fig. 3B), they all have highly negative N termini (Fig. 4A), which 
distinguishes them from any other protein in the cell. Together, 
these characteristics may explain why animals use a dedicated en-
zyme to Nt-acetylate actin. Curiously, the only other substrate- 
dedicated NAT, NatD, Nt-acetylates histones H2A and H4 (6), which, 
along with actin, are among the most highly conserved proteins in 
nature. Nt-acetylation masks the positive charge of the -amino 
group on actin, thus accentuating the overall negative charge of the 
N terminus, which is prominently exposed in the filament and par-
ticipates in interactions with many ABPs (9). Consistently, the lack 
of actin Nt-acetylation has profound effects on filament assembly in 
cells, including increased filopodia and lamellipodia formation and 
faster cell migration, whereas, in vitro, it decreases the rates of fila-
ment depolymerization and formin-mediated elongation (7).
Despite ~80% of human proteins being Nt-acetylated, not a single 
NAT-substrate structure existed thus far, such that the NAA80-
actin- profilin structures described here offer a rare look into the 
mechanism of Nt-acetylation. These structures reveal a rather 
unique case of enzyme-substrate adaptation, including (i) NAA80’s 
preference for G- versus F-actin, which ensures that Nt-acetylation 
precedes polymerization, with the polymer being the functionally 
most relevant form of actin (Fig. 1 and fig. S2); (ii) NAA80’s ability 
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to recognize not only G-actin but also the actin-profilin complex, 
which is the most abundant form of G-actin in cells (Figs. 2 and 3); 
and (iii) an NAA80 structure specifically tailored to recognize the 
highly conserved actin surface and the relatively variable but nega-
tively charged actin N terminus (Fig. 3 and fig. S4, A to C). Below, 
we expand on the implications of each of these observations.
The structures explain why the binding of NAA80 to Tpm- 
decorated actin filaments is unfavorable in cells (Fig. 1, D and E), 
despite taking place at lower affinity in vitro (Figs. 1F and 2C). Tpm 
can occupy three different positions on the actin filament (blocked, 
closed, and open), with the latter two being separated by azimuthal 






Fig. 4. NAA80 specifically recognizes actin-profilin through extensive surface contacts. (A) Alignment of the N-terminal sequences of the six human actin isoforms 
as they exist in cells after processing and Nt-acetylation. (B) E. coli– and mammalian cell–expressed NAA80 can acetylate N-terminal peptides derived from all six human 
actin isoforms but not a prototypical NatA/NAA10-substrate peptide, shown as a control (see fig. S9 for full peptide sequences and characterization). Acetylation is reported 
as the amount of radioactive product measured in disintegrations per minute (DPM). Error bars are ±SD (n = 3; red open circles). The statistical significance of the mea-
surements was determined using an unpaired two-sided Student’s t test, comparing each of the actin peptides to the control (*P < 0.05, **P < 0.01, ***P < 0.001). 
(C) Surface representation of the structure of NAA80, showing the actin-binding (yellow) and profilin-binding (green) interfaces and groups of residues replaced in mutants 
M1 (V220D, F221D, R225D, and L226D; blue), M2 (L230D and L231D; cyan), and M3 (P266D and P267D; orange). (D) In vitro activity of NAA80FL mutants M1, M2, M3, and 
M4 (M1 + M3) immunoprecipitated from HeLa cells toward N-terminal actin peptides (fig. S9). The activity was normalized against the expression level and immuno-
precipitation efficiency of each construct. Error bars are ±SD (n = 3; red open circles). The statistical significance of the measurements was determined using an unpaired 
two-sided Student’s t test (n.s., P ≥ 0.05, **P < 0.01, ***P < 0.001). (E) ITC titrations of NAA80FL mutant M4 (CoA) into Ac--actin–profilin (LatB) using the indicated experi-
mental conditions. The data could not be fit to a binding isotherm. Open symbols correspond to a control titration into buffer. (F) NAA80 mutant M4 cannot acetylate 
nonacetylated /-actin, as monitored by Western blot analysis using acetylation- and isoform-specific anti–Ac--actin antibody. Shown as a control is Ac-/-actin purified 
from WT cells, and loading is controlled by anti–pan-actin staining. (G) Rescue of /-actin acetylation in NAA80 KO cells transfected with V5-NAA80FL WT and mutants M1 
to M4 analyzed by Western blot using acetylation- and isoform-specific anti-actin antibodies. Anti-V5 staining shows levels of NAA80 expression, whereas anti–pan-actin 
and anti-vinculin staining provide loading controls (see also fig. S2C). For each mutant, the intensities of the Ac--actin and Ac--actin bands were first normalized to the 
expression level (V5 signal) and then to the level of WT Ac-/-actin. Error bars are ±SD for n = 6 (WT, M2, and M3) or n = 3 (M1 and M4) independent experiments shown 
as red open circles. The statistical significance of the measurements was determined using a two-way analysis of variance (ANOVA) test between WT and each mutant 
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favorable blocked state (25). NAA80 overlaps with Tpm in the blocked 
state, so it can only bind to the filament after “pushing” Tpm to the 
closed or open states (fig. S6), which it can achieve but, at an energy 
cost, reflected in its lower affinity for Tpm-decorated filaments. It is 
less clear why NAA80 binds monomers with higher affinity than 
naked filaments. NAA80 does not appear to compete with either 
profilin or DNase I for binding to monomeric actin (Fig. 2, A and B, 
and fig. S3C), with the binding surfaces of these two proteins coin-
ciding with the two major intersubunit contacts along the long-
pitch helix of the filament (fig. S3D). One possibility is that NAA80’s 
weaker affinity for the filament results from the conformational 
change that takes place upon actin polymerization (26). It is also 
possible that the Pro-rich insert of NAA80 partially hinders binding 
to filaments.
The structures also illuminate NAA80’s preference for actin- 
profilin compared to actin alone. Thus, NAA80 is the only NAT 
that has a long proline-rich loop inserted before the last -strand of 
the catalytic domain, featuring a canonical profilin-binding se-
quence (fig. S1A). We have shown here that NAA80 binds profilin 
directly (Fig. 2F) and that the interaction is mediated by the Pro-rich 
loop (Fig. 3A). We have further shown that profilin acts as a chap-
erone for actin Nt-acetylation (Fig. 2G) by significantly enhancing 
the Nt-acetylation efficiency of NAA80 toward the actin-profilin 
substrate.
NAA80 is distinguished from other NATs in that it has a wide 
open and positively charged substrate-binding cleft (fig. S5B), adapted 
to accommodate the variable, negatively charged N termini of actin 
isoforms (fig. S4, A to C). On the other hand, NAA80 presents a 
surface to the actin substrate entirely different from that of other 
NATs (Fig. 3C and fig. S5A). Together, the structural and func-
tional features uncovered here explain why actin is NAA80’s sole 
substrate in the cell and why, in its absence, no other NAT can Nt- 




The gene encoding human NAA80 (UniProt ID: Q93015-2) was 
obtained using Transcriptor Reverse Transcriptase (Roche) from 
human embryonic kidney 293 cells cDNA (complementary DNA) 
(7). For bacterial expression, NAA80FL and NAA80N (residues 78 
to 308) were cloned between the NdeI and XhoI sites of vector 
pTYB12 [New England Biolabs (NEB)], which comprises a chitin- 
binding domain for affinity purification and an intein domain for 
self-cleavage of the affinity tag after purification. The M4 mutant 
(V220D, F221D, R225D, L226D, P266D, and P267D) was generated 
from NAA80FL using the QuickChange mutagenesis kit (Stratagene). 
The proteins were expressed in ArcticExpress(DE3) RIL cells (Agilent 
Technologies), grown in Terrific Broth (TB) medium for 6 hours at 
37°C to a density of ~1.5 to 2 optical density at 600 nm (OD600), 
followed by 24 hours at 10°C in the presence of 0.4 mM isopropyl- 
-d-thiogalactoside (IPTG). Cells were harvested by centrifugation, 
resuspended in 20 mM Hepes (pH 7.5), 500 mM NaCl, 1 mM EDTA, 
and 1 mM phenylmethanesulfonyl fluoride (PMSF) and lysed 
using a microfluidizer (Microfluidics). The proteins were first puri-
fied on a chitin affinity column, according to the manufacturer’s 
protocol (NEB), followed by ion exchange chromatography using a 
Mono S column (GE Healthcare) in 20 mM MES (pH 5.5 for NAA80 
or pH 6.5 for NAA80N) and a 50 to 1000 mM NaCl gradient. A final 
step of purification was performed on a gel filtration SD200HL 
26/600 column (GE Healthcare) in 20 mM Hepes (pH 7.5) and 
100 mM NaCl.
The cDNA encoding human profilin-1 (UniProt ID: P07737) 
was purchased from the American Type Culture Collection (ATCC) 
and cloned between the SapI and EcoRI sites of vector pTYB11 
(NEB). Profilin was expressed in BL21(DE3) cells (Invitrogen), 
grown in TB medium at 37°C to a density of ~1.5 to 2 OD600, fol-
lowed by 16 hours at 20°C in the presence of 0.5 mM IPTG. Cells 
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Fig. 5. There is one NAA80 molecule for every 3000 actin molecules in cells. (A) Western blot analysis of the amount of endogenous NAA80 in HAP1 WT cell lysates 
(left) compared to specific amounts of purified NAA80 added to NAA80 KO HAP1 cell lysates (right) and the resulting standard curve. The arrow points to the NAA80 band 
detected by a custom-made antibody. (B) Western blot analysis of the amount of endogenous actin in HAP1 WT cell lysates (left) compared to specific amounts of purified 
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(pH 7.5), 500 mM NaCl, 1 mM EDTA, and 1 mM PMSF, and lysed 
using a microfluidizer. The protein was purified on a chitin affinity 
column, according to the manufacturer’s protocol, followed by gel 
filtration on a SD75HL 16/600 column (GE Healthcare) in 20 mM 
Hepes (pH 7.5) and 100 mM NaCl.
The cDNA encoding human gelsolin (UniProt ID: P06396) was 
purchased from Open Biosystems (GE Healthcare). Gelsolin sub-
domain 1 (also called GS1, residues 1 to 125) was cloned between 
the NdeI and EcoRI sites of vector pTYB12 and expressed and puri-
fied as described for profilin above. The fragment encoding gelsolin 
subdomains 4 to 6 GS4-GS6, residues 434 to 782) was cloned be-
tween the XhoI and EcoRI sites of vector pCold I (Clontech Labora-
tories) and expressed in Rosetta (DE3) cells (Novagen). Cells were 
grown in TB medium at 37°C to a density of 0.8 OD600, followed by 
24 hours at 15°C in the presence of 0.3 mM IPTG. Cells were har-
vested by centrifugation, resuspended in 50 mM tris-HCl (pH 8.0), 
500 mM NaCl, 5 mM imidazole, and 1 mM PMSF, lysed using a 
microfluidizer, and purified on a Ni–NTA (nitrilotriacetic acid) 
affinity column (QIAGEN) according to the manufacturer’s 
protocol.
Ac-/-actin and non-Ac-/-actin were purified from WT and 
NAA80 KO HAP1 cells (Horizon Discovery), respectively, using 
GS4-GS6’s calcium-activated switch (27) as an affinity purifi-
cation method, as we previously described (7). Ac--actin and 
Tpm were purified from rabbit skeletal muscle as previously de-
scribed (28).
The plasmid (EGPF-N backbone) carrying human -actin–T4 
hybrid with C-terminal His-tag was a gift from H. Higgs (Dartmouth 
Medical School). The hybrid construct was expressed in a 100-ml 
culture of mammalian Expi293 cells and purified on a Ni-NTA af-
finity column according to the manufacturer’s protocol. DNase I 
was purchased from VWR.
The concentration of NAA80 and its complexes with actin and 
actin-profilin were determined using the Coomassie Plus (Bradford) 
assay (Thermo Fisher Scientific). The concentration of actin was 
determined spectrophotometrically at 290 using extinction co-
efficient of 26,600 M−1 cm−1. The concentration of other proteins 
was determined at 280 nm, using the following coefficients: profilin1, 
18,450 M−1 cm−1; GS1, 21,430 M−1 cm−1; GS4-GS6, 65,890 M−1 cm−1; 
DNase1, 38,850 M−1 cm−1; Tpm, 8940 M−1 cm−1.
Plasmids for mammalian cell expression
The NAA80 gene was inserted into vector pcDNA3.1/V5-His 
TOPO TA (Invitrogen), as we have described (7). The catalytically 
inactive mutant NAA80CM (W105F, R170Q, G173D, and Y205F) 
and other mutants (Fig. 4D) were generated using the Q5 Site- 
Directed Mutagenesis Kit (NEB). The NAA80 constructs were cloned 
into vector pcDNA4/HisMax TOPO TA (Invitrogen), in which 
the Xpress tag was replaced with a V5 tag. For imaging, NAA80FL 
and NAA80N were cloned between the BglII and HindIII sites of 
vector EGFP-C1 (Clontech Laboratories).
Human cell culture
HAP1 WT and NAA80 KO cells (Horizon Discovery) were grown 
in Iscove's modified Dulbecco's medium, 10% fetal bovine serum 
(FBS), and 1% penicillin-streptomycin at 37°C and 5% CO2. Cells 
were passaged and their diploid status confirmed on an Accuri BD 
C6 flow cytometer using propidium iodide staining. HeLa cells 
(ATCC) were cultured in Dulbecco’s modified Eagle’s medium, 
10% FBS, and 1% penicillin-streptomycin. Cells were seeded on 
plates or coverslips and transfected with X-tremeGENE 9 (Roche) 
or FuGENE (Promega). Cells were harvested, imaged alive, or fixed 
24 to 48 hours after transfection.
Immunofluorescence
HeLa, HAP1 WT, or NAA80 KO cells were transfected with 1 g of 
GFP-NAA80, with or without cotransfection with mCherry empty 
vector, and fixed 48 hours after transfection with 4% (w/v) para-
formaldehyde for 10 min. For F-actin visualization, cells were per-
meabilized with 0.5% Tween 20 [in phosphate-buffered saline 
(PBS)] for 15 min and incubated with 100 nM Alexa Fluor 546 phal-
loidin (Invitrogen) for 30 min at room temperature (RT). Covers-
lips were mounted on a drop of ProLong Diamond Antifade Mountant 
(Invitrogen) and imaged within 48 hours, using an Eclipse TE2000-U 
inverted microscope (Nikon) equipped with a PlanApo 100×/1.3 
numerical aperture objective and a Cascade 512B charge-coupled 
device camera (Photometrics) controlled by the MetaMorph imag-
ing software (Molecular Devices). The images were level-adjusted 
with Adobe Photoshop. Line-scans were taken with the program 
Fiji (ImageJ).
For live-cell imaging, HeLa cells were transfected with 1 g 
of GFP-NAA80, together with one of the following markers: 
mCherry-LifeAct, DsRed-Mito, mCherry-Sec61B, or mCherry- 
Calnexin. The cells were imaged 24 hours after transfection using 
the same microscope.
Cell fractionation assay
HAP1 WT and NAA80 KO cells were harvested by scraping and 
resuspended in 750 l of prewarmed LAS buffer [50 mM Pipes 
(pH 6.9), 50 mM NaCl, 5 mM MgCl2, 5 mM EGTA, 5% (v/v) 
glycerol, 0.1% NP-40, 0.1% Triton X-100, 0.1% Tween 20, 0.1% 
-mercaptoethanol, 1 mM ATP, 0.001% Antifoam C, and a protease 
inhibitor cocktail consisting of 0.4 mM tosyl arginine methyl ester, 
1.5 mM leupeptin, 1 mM pepstatin A, and 1 mM benzamidine]. Cells 
were lysed using the EMBL (European Molecular Biology Laboratory) 
cell cracker (ball size, 8.010 mm) with 16 strokes or by 10 passages 
through a 25-gauge needle. The lysate was clarified by centrifugation 
(400g for 5 min at RT). The supernatant (100 l) was collected, and 
actin polymerization was initiated by addition of 2 mM MgCl2, 0.2 
mM EGTA, 100 mM KCl, and 1 M phalloidin and by incubation 
for 1 hour at 37°C. F-actin and F-actin–binding proteins were pel-
leted by ultracentrifugation (270,000g for 1 hour at 4°C). The su-
pernatant (G-actin fraction) was collected, and the pellet (F-actin 
fraction) was washed twice with Milli-Q water and resuspended in 
100 l of 8 M urea. After addition of SDS loading buffer, the samples 
were separated by SDS–polyacrylamide gel electrophoresis (PAGE) 
and analyzed by Western blotting, using the following antibodies: 
custom anti-NAA80 polyclonal rabbit (1:200; BioGenes, Germany), 
anti–pan-actin polyclonal rabbit (1:2000; Cell Signaling Technology, 
4968), anti-mDia1 monoclonal rabbit (1:2000; Abcam, ab129167), 
anti-profilin monoclonal rabbit (1:2000; Abcam, ab50667).
For the experiment with V5-tagged NAA80 constructs, cells were 
transfected with 2 to 6 g of V5-NAA80FL, NAA80CM-V5 (catalyti-
cally inactive mutant), or V5-NAA80N. The same number of cells 
per cell line (2 × 106) was washed briefly 24 hours after transfection 
with PBS and processed as above. In the Western blotting analysis, 
anti-V5 monoclonal mouse antibody (1:1000; Invitrogen, R960CUS) 
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In vitro acetylation of actin and actin-profilin
Non–Ac-/-actin (purified from NAA80 KO cells) at 10 M in 
G-buffer, alone or in complex with profilin (prepared by mixing at 
1:1.2 molar ratio), was incubated with E. coli–expressed NAA80FL at 
molar ratios of 1:50, 1:100, 1:200, and 1:400 (NAA80:actin) and 
50 M AcCoA. At the indicated time points (5, 10, 20, and 60 min; 
Fig. 2G and fig. S8), 10 l of each sample was transferred to 10 l of 
SDS-PAGE loading buffer. The samples were analyzed by Western 
blotting using isoform- and acetylation-specific mouse monoclonal 
anti–Ac--actin (1:5000; Abcam, ab6276) and rabbit polyclonal 
anti–pan-actin (1:2000; Cell Signaling Technology, 4968) antibodies. 
Densitometric analysis was performed using a G:BOX scanner 
(Syngene) and the Image Lab 6.0.1 software (Bio-Rad). For each blot, 
the band intensities were normalized to the 1:50 NAA80:actin- profilin 
band, which was always the strongest. Mean relative intensities and 
SD were calculated from three independent experiments (n = 3).
Immunoprecipitation of NAA80 constructs
For immunoprecipitation of V5-NAA80 constructs, 7.5 × 106 HeLa 
cells were transfected with 12 g of DNA and X-tremeGENE 9. After 
24 hours, cells were harvested and lysed in 1.2 ml of IPH buffer 
[50 mM tris-HCl (pH 8.0), 150 mM NaCl, 0.1% NP-40, and EDTA- 
free protease inhibitor cocktail (Roche)] for 15 min at 4°C. Lysates 
were clarified by centrifugation (17,000g for 15 min at 4°C). The 
supernatants were incubated for 4 hours at 4°C with 6 g of anti-V5 
antibody (Invitrogen, R960CUS), followed by the addition of 25 l 
of Protein A/G Mix Magnetic Beads (Millipore), and washed three 
times in IPH buffer. After incubation for 16 hours and washing two 
times in IPH buffer and once in acetylation buffer [50 mM tris-HCl 
pH 7.4, 1 mM EDTA, 1 mM dithiothreitol (DTT), and 10% (v/v) 
glycerol], the samples were used in [14C]-Ac-CoA peptide acetylation 
assays.
[14C]-AcCoA–based peptide acetylation assay
The peptide acetylation assay was performed as we have described 
(7, 29). Briefly, NAA80 (E. coli–expressed or immunoprecipitated 
from HeLa cells) was mixed with 300 M synthetic peptides (syn-
thesized and quality-controlled by BioGenes; fig. S9) and 50 M 
isotope-labeled [14C]-AcCoA (PerkinElmer) in a total volume of 
25 l of acetylation buffer (see above). The samples were incubated 
for 1 hour at 37°C, and 20 l was then transferred onto P81 phos-
phocellulose filter discs (Millipore). The discs were washed three 
times with 10 mM Hepes (pH 7.4) and dried before they were added 
to 5 ml of scintillation cocktail Ultima Gold F (PerkinElmer). The 
amount of incorporated [14C]-Ac was determined by a Tri-Carb 
2900TR Liquid Scintillation Analyzer (PerkinElmer). The activity 
was corrected for the amount of immunoprecipitated NAA80 de-
termined by Western blot analysis.
Rescue of actin acetylation in NAA80 KO cells
NAA80 KO cells were split 1:3, seeded in 10-cm plates, cultured 
overnight, and transfected with varying amounts of V5-NAA80 
WT and mutant (M1 to M4) DNA as follows: WT, 12 g, n = 6; M1 
(V220D, F221D, R225D, and L226D), 2.1 g, n = 3; M2 (L230D and 
L231D), 12 g, n = 6; M3 (P266D and P267D), 1.5 g, n = 6; M4 
(V220D, F221D, R225D, L226D, P266D, and P267D), 4 g, n = 3. 
Cells were harvested by trypsinization after 16 hours and lysed in 
IPH buffer (see above), and lysates were clarified by centrifugation 
at 17,000g for 5 min. The clarified lysates were loaded onto 8 to 16% 
SDS-PAGE gels (Bio-Rad) and run for 35 min at 200 V. Gels were 
transferred to polyvinylidene difluoride membrane and probed 
with anti–Ac--actin (monoclonal mouse, 1:5000; Abcam, ab6276), 
anti–Ac--actin (monoclonal mouse, 1:5000; Abcam, ab123034), 
anti–pan-actin (polyclonal rabbit, 1:2000; Cell Signaling Tech-
nology, 4968), anti-V5 (monoclonal mouse, 1:3000; Invitrogen, 
R960CUS), and anti-vinculin (monoclonal rabbit, 1:1000 to 2000; 
Abcam, ab129002) antibodies. The densitometric analysis of the 
signal from horseradish peroxidase–conjugated secondary anti-
bodies was performed using Image Lab 6.0.1 software (Bio-Rad). 
For each NAA80 variant, the bands for Ac--actin, Ac--actin, and 
V5 were quantified relative to the WT signal. To account for the 
different expression levels of NAA80 mutants, Ac--actin and 
Ac--actin signals were divided by the corresponding V5 signal. 
The SD for the ratio was calculated according to the following for-
mula:  SD ratio =  (  
actin _V5 ) ×  √ 
_________________
   ( CV actin ) 2 +  ( CV V5 ) 2 , where  CV =  SD _ mean of 
the V5 or actin signals. The means were compared using a two-way 
analysis of variance (ANOVA) with Dunnett’s multiple comparison 
test and a significance threshold of 0.05 for the adjusted P value 
(GraphPad Software).
Quantification of NAA80 and actin abundance in cells
The quantification of NAA80 and actin was performed in WT 
HAP1 cells. For NAA80, a standard curve was first obtained by add-
ing known amounts of E. coli–expressed NAA80FL to lysates from a 
specific number of HAP1 NAA80 KO cells. For actin, a standard 
curve was obtained using known amounts of tissue-purified Ac--
actin. For the quantification of NAA80, a custom antibody was 
raised against E. coli–expressed, tag-free NAA80N (polyclonal rabbit, 
1:500; BioGenes, Germany), whereas actin was quantified using a 
commercial anti–pan-actin antibody (monoclonal mouse, 1:2000; 
Abcam, ab14128). Cell pellets were resuspended and lysed by incu-
bation in IPH buffer (see above) for 20 min on ice, followed by cen-
trifugation for 5 min at 17,000g. The standard curves and samples 
(n = 4) were quantified by Western blotting and densitometry analyses.
Isothermal titration calorimetry
ITC measurements were carried out on a VP-ITC apparatus (MicroCal). 
Before the experiments, samples were dialyzed for 2 days against 
20 mM Hepes (pH 7.5), 100 mM NaCl, 0.2 mM ATP, and 1 mM 
DTT (ITC buffer). In experiments with NAA80, CoA or AcCoA (as 
indicated in the figures) was added to the buffer at 1.5 molar excess 
over the NAA80 concentration. In experiments with actin and actin- 
profilin, LatB was added to the buffer at a 1.2 molar excess over the 
actin concentration. The actin-profilin complex was prepared by 
mixing actin and profilin-1 at a 1:1.2 molar ratio. The higher- 
affinity complexes of actin-GS1 and actin–DNase I were prepared 
by mixing at a molar ratio of 1:1.5, followed by purification by gel 
filtration on a SD200HL 26/600 column (GE Healthcare) in ITC 
buffer to remove the excess of GS1 or DNase I. The experiments 
were carried out at 20°C, except for the titration of profilin into N, 
whose weaker binding yielded a stronger signal at 30°C. Titrations 
consisted of 10-l injections, lasting for 10 s, with an interval of 300 s 
between injections. The concentrations of the proteins in the syringe 
and the cell (volume of 1.44 ml) are listed in the figures. The heat of 
binding was corrected for the heat of injection, determined by in-
jecting titrant into buffer (open symbols in figures). Data were ana-
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F-actin cosedimentation assay
Actin at 20 M in G-buffer was polymerized by the addition of 100 mM 
KCl, 2 mM MgCl2, and 1 mM EGTA and incubation for 30 min at 
RT. Tpm-decorated actin filaments were formed by the addition of 
6.3 M Tpm (actin:Tpm ratio of 3.2:1). Cofilin-decorated filaments 
were formed by addition of 5× molar excess of human cofilin 2. Be-
fore the experiments, NAA80 in 20 mM Hepes (pH 7.5) and 100 mM 
NaCl (NAA80 buffer) was centrifuged at 278,000g for 30 min to 
remove aggregates. The samples were prepared by mixing a fixed 
concentration of F-actin (4 M ± 1.2 M Tpm) with increasing con-
centrations of NAA80 (0 to 24 M) and adjusting the sample volume 
to 150 l with NAA80 buffer (n = 3 for each concentration). The 
samples were incubated for 1 hour at RT and pelleted by centrifuga-
tion at 278,000g for 30 min. The supernatant was collected, and the 
pellet was gently washed with 150 l of NAA80 buffer and then re-
suspended in 150 l (same buffer). Equal volumes of supernatant 
and resuspended pellet fractions were analyzed by SDS-PAGE (fig. S7). 
The densitometric analysis of the bands in the gels was performed 
using a G:Box gel scanner (Syngene) and the program GelBandFitter, 
designed to analyze closely spaced bands (30). The ratio of NAA80 
bound to F-actin was determined from the ratio of the correspond-
ing band intensities in the same pellet lane, corrected for the per-
centage of actin in the supernatant lane. The data were fitted with 
the equation  [NAA  80 bound ] _[F-actin] =  B max  
[NAA  80 free ] ____________  ( K D + [NAA  80 free ] ), in which [NAA80free] 
is [NAA80total] − [NAA80bound] and the   
[NAA  80 bound ]_
[F-actin]
   ratio was expressed 
as a function of [NAA80total]. The calculations were performed us-
ing the program Origin. SEM values were determined from three 
independent experiments (fig. S7).
Crystallography
The complexes of /-actin/profilin/NAA80N-AnCoA, Ac--actin–
profilin–NAA80N-CoA, and Ac--actin–profilin/NAA80N-AcCoA 
were formed by mixing the three proteins at 1:1.2:1.2 molar ratio 
in 20 mM Hepes (pH 7.5), 50 mM NaCl, 0.2 mM ATP, 0.2 mM 
CaCl2, 1 mM DTT, and 50 M LatB. The concentration of the 
NAA80 cofactors (AnCoA, CoA, and AcCoA) was 150 M. AnCoA 
was a gift from R. Marmorstein (University of Pennsylvania). The 
complexes were concentrated to 3 to 4 mg ml−1 using Amicon 
Ultra centrifugal filters (Millipore). Before crystallization, samples 
were centrifuged at 278,000g for 30 min to remove potential aggre-
gates. Crystals were obtained at 16°C using the hanging drop vapor 
diffusion method. The crystallization drops at 2 l consisted of a 
1:1 (v/v) mixture of protein solution and a well solution containing 
100 mM MES (pH 6.5), 200 mM NH4NO3, and 16% (v/v) poly-
ethylene glycol 3350. Crystal quality was improved through succes-
sive rounds of microseeding using an Oryx4 crystallization robot 
(Douglas Instruments). For data collection, crystals were flash- 
frozen in liquid nitrogen from a cryo-solution consisting of well 
buffer and 30% (v/v) glycerol.
X-ray diffraction datasets were collected at 100 K at beamline F1 
(MacCHESS, Cornell University). The datasets were indexed and 
scaled with the program HKL2000 (HKL Research). The structures 
were determined by molecular replacement, using as a search model, 
the 1.5-Å resolution structure of actin-profilin with a VASP frag-
ment [Protein Data Bank (PDB) entry 2PBD (18)]. Model building 
and refinement were performed with the programs Coot (31) and 
Phenix (32), respectively. Figures of the structures were prepared 
with the program PyMOL (Schrödinger).
Statistical methods
The statistical significance of the measurements was determined us-
ing an unpaired two-way Student’s t test or a two-way ANOVA test, 
both implemented in the program Prism v8.1.2 (GraphPad Software). 
The results were deemed nonsignificant (n.s.) for P ≥0.05. The 
details are reported in the figure legends.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/6/15/eaay8793/DC1 
View/request a protocol for this paper from Bio-protocol.
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